David P. Schenkein

Agios Pharmaceuticals

President and Chief Executive Officer

Overview

David P. Schenkein made an average of $4.4M in compensation at Agios Pharmaceuticals from 2011 to 2018.

Annual data

2018

In 2018, David P. Schenkein earned a total compensation of $8.2M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking650 out of 8,356
Percentile92.2%

David P. Schenkein's 2018 compensation ranked 650th out of 8,356 executive pay records tracked by us this year.

Schenkein earned more than 92.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking27 out of 557
Percentile95.2%

In the industry group of Drugs, Schenkein's pay ranked 27th out of 557 executive pay records tracked by us in 2018.

Schenkein earned more than 95.2% of executives in this group.

Non-Equity Incentive Plan$507,813
Option Awards$5,160,125
Salary$625,000
Stock Awards$1,893,938
Other$12,448
Total$8,199,324

Schenkein received $5.2M in option awards, which accounts for 62.93% of total compensation.

Schenkein also received $507.8K in non-equity incentive plan, $625K in salary, $1.9M in stock awards and $12.4K in other compensation.

David P. Schenkein's Pay$8,199,324
Median Employee's Pay$345,181
Pay Ratio24 : 1

For fiscal year 2018, the annual total compensation for David P. Schenkein was $8,199,324 and for the median employee at Agios Pharmaceuticals was $345,181. The resulting ratio of David P. Schenkein's pay to the pay of median employee was 24 to one.

2017

In 2017, David P. Schenkein earned a total compensation of $6M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking1,362 out of 13,167
Percentile89.7%

David P. Schenkein's 2017 compensation ranked 1,362nd out of 13,167 executive pay records tracked by us this year.

Schenkein earned more than 89.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking79 out of 1,396
Percentile94.3%

In the industry group of Drugs, Schenkein's pay ranked 79th out of 1,396 executive pay records tracked by us in 2017.

Schenkein earned more than 94.3% of executives in this group.

Non-Equity Incentive Plan$456,300
Option Awards$4,921,476
Salary$585,040
Other$9,548
Total$5,972,364

Schenkein received $4.9M in option awards, which accounts for 82.40% of total compensation.

Schenkein also received $456.3K in non-equity incentive plan, $585K in salary and $9.5K in other compensation.

2016

In 2016, David P. Schenkein earned a total compensation of $3.5M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking2,599 out of 13,853
Percentile81.2%

David P. Schenkein's 2016 compensation ranked 2,599th out of 13,853 executive pay records tracked by us this year.

Schenkein earned more than 81.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking183 out of 1,472
Percentile87.6%

In the industry group of Drugs, Schenkein's pay ranked 183rd out of 1,472 executive pay records tracked by us in 2016.

Schenkein earned more than 87.6% of executives in this group.

Non-Equity Incentive Plan$340,800
Option Awards$2,582,051
Salary$568,000
Other$9,928
Total$3,500,779

Schenkein received $2.6M in option awards, which accounts for 73.76% of total compensation.

Schenkein also received $340.8K in non-equity incentive plan, $568K in salary and $9.9K in other compensation.

2015

In 2015, David P. Schenkein earned a total compensation of $10.1M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking493 out of 13,574
Percentile96.4%

David P. Schenkein's 2015 compensation ranked 493rd out of 13,574 executive pay records tracked by us this year.

Schenkein earned more than 96.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking50 out of 1,484
Percentile96.6%

In the industry group of Drugs, Schenkein's pay ranked 50th out of 1,484 executive pay records tracked by us in 2015.

Schenkein earned more than 96.6% of executives in this group.

Non-Equity Incentive Plan$295,000
Option Awards$9,290,670
Salary$517,500
Other$10,052
Total$10,113,222

Schenkein received $9.3M in option awards, which accounts for 91.87% of total compensation.

Schenkein also received $295K in non-equity incentive plan, $517.5K in salary and $10.1K in other compensation.

2014

In 2014, David P. Schenkein earned a total compensation of $4.4M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking1,901 out of 12,876
Percentile85.2%

David P. Schenkein's 2014 compensation ranked 1,901st out of 12,876 executive pay records tracked by us this year.

Schenkein earned more than 85.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking160 out of 1,310
Percentile87.8%

In the industry group of Drugs, Schenkein's pay ranked 160th out of 1,310 executive pay records tracked by us in 2014.

Schenkein earned more than 87.8% of executives in this group.

Non-Equity Incentive Plan$371,250
Option Awards$3,486,013
Salary$500,000
Other$1,978
Total$4,359,241

Schenkein received $3.5M in option awards, which accounts for 79.97% of total compensation.

Schenkein also received $371.3K in non-equity incentive plan, $500K in salary and $2K in other compensation.

2013

In 2013, David P. Schenkein earned a total compensation of $1.6M as President and Chief Executive Officer at Agios Pharmaceuticals.

Ranking4,639 out of 11,965
Percentile61.2%

David P. Schenkein's 2013 compensation ranked 4,639th out of 11,965 executive pay records tracked by us this year.

Schenkein earned more than 61.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking318 out of 1,095
Percentile71.0%

In the industry group of Drugs, Schenkein's pay ranked 318th out of 1,095 executive pay records tracked by us in 2013.

Schenkein earned more than 71.0% of executives in this group.

Non-Equity Incentive Plan$204,000
Option Awards$957,057
Salary$425,000
Other$3,005
Total$1,589,062

Schenkein received $957.1K in option awards, which accounts for 60.23% of total compensation.

Schenkein also received $204K in non-equity incentive plan, $425K in salary and $3K in other compensation.

2012

In 2012, David P. Schenkein earned a total compensation of $698.3K as Chief Executive Officer at Agios Pharmaceuticals.

Ranking7,340 out of 10,949
Percentile33.0%

David P. Schenkein's 2012 compensation ranked 7,340th out of 10,949 executive pay records tracked by us this year.

Schenkein earned more than 33.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking484 out of 850
Percentile43.1%

In the industry group of Drugs, Schenkein's pay ranked 484th out of 850 executive pay records tracked by us in 2012.

Schenkein earned more than 43.1% of executives in this group.

Non-Equity Incentive Plan$136,000
Option Awards$134,513
Salary$425,000
Other$2,764
Total$698,277

Schenkein received $425K in salary, which accounts for 60.86% of total compensation.

Schenkein also received $136K in non-equity incentive plan, $134.5K in option awards and $2.8K in other compensation.

2011

In 2011, David P. Schenkein earned a total compensation of $611.2K as Chief Executive Officer at Agios Pharmaceuticals.

Ranking7,090 out of 10,038
Percentile29.4%

David P. Schenkein's 2011 compensation ranked 7,090th out of 10,038 executive pay records tracked by us this year.

Schenkein earned more than 29.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking443 out of 705
Percentile37.2%

In the industry group of Drugs, Schenkein's pay ranked 443rd out of 705 executive pay records tracked by us in 2011.

Schenkein earned more than 37.2% of executives in this group.

Non-Equity Incentive Plan$170,000
Option Awards$13,462
Salary$425,000
Other$2,764
Total$611,226

Schenkein received $425K in salary, which accounts for 69.53% of total compensation.

Schenkein also received $170K in non-equity incentive plan, $13.5K in option awards and $2.8K in other compensation.